LBEC0101: Clinical Trials

4 trials of LBEC0101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 32Completed 1, Unknown 1

Follow LBEC0101: new trials by email Literature Review of LBEC0101 trials Research Report on LBEC0101

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX)
LBEC0101 - Rheumatoid Arthritis
Phase 3CompletedLG Life Sciences1482016-04-012018-07-06
A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Enbrel, LBEC0101 - Arthritis, Rheumatoid
Phase 3UnknownLG Life Sciences3722015-02-012016-01-06
Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®
LBEC0101 (Etanercept 25mg), Enbrel (Etanercept 25mg) - Healthy
Phase 1CompletedLG Life Sciences482012-11-012015-01-30
Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®
LBEC0101, Enbrel - Healthy
Phase 1CompletedLG Life Sciences362010-06-012011-02-18

Conditions studied

Arthritis, Rheumatoid (2)

Sponsors

LG Life Sciences (4)

Countries

South Korea (4)  ·  Japan (1)

Top investigators

Kyung-Sang Yu, M.D., Ph.D. (2)

Results publications

PMID 28551775, PMID 29259050, PMID 31113455